West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2024, West had total debt outstanding of $203 million. West has ...
infectiousdiseaseadvisor.com23h
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.